Literature DB >> 10688863

Manipulating the germline: its impact on the study of carcinogenesis.

A R Clarke1.   

Abstract

Over the past two decades, the mouse has established itself as the primary organism in which to investigate the fundamental mechanisms of carcinogenesis and to model human neoplasia. The principal reason underlying such dominance almost certainly arises out of our ever increasing ability to manipulate the murine germline. Over the past 20 years we have moved from a position where animal models arose either spontaneously or were generated through exposure to carcinogen to a position in which it is possible to create and study precise mutations of choice. The most recent advances in inducible and conditional technologies now open the possibility for both temporal and tissue-specific gene manipulation. Each of these technological breakthroughs has facilitated significant steps forward in our understanding of the genetic basis of tumorigenesis. This review will highlight some of the major advances in the production and use of murine models of neoplasia over the last two decades.

Entities:  

Mesh:

Year:  2000        PMID: 10688863     DOI: 10.1093/carcin/21.3.435

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  5 in total

Review 1.  Discovering pluripotency: 30 years of mouse embryonic stem cells.

Authors:  Martin Evans
Journal:  Nat Rev Mol Cell Biol       Date:  2011-09-23       Impact factor: 94.444

Review 2.  Mouse models in oncogenesis and cancer therapy.

Authors:  M V Céspedes; I Casanova; M Parreño; R Mangues
Journal:  Clin Transl Oncol       Date:  2006-05       Impact factor: 3.405

3.  CCL3 Promotes Proliferation of Colorectal Cancer Related with TRAF6/NF-κB Molecular Pathway.

Authors:  Xiaoqiang Ma; Jinda Su; Shaohui Zhao; Yaqin He; Shuzhen Li; Xiaoliang Yang; Sifan Zhai; Shikuo Rong; Xin Zhang; Guangxian Xu; Xiaoliang Xie
Journal:  Contrast Media Mol Imaging       Date:  2022-07-12       Impact factor: 3.009

Review 4.  The use of genetically modified mice in cancer risk assessment: challenges and limitations.

Authors:  David A Eastmond; Suryanarayana V Vulimiri; John E French; Babasaheb Sonawane
Journal:  Crit Rev Toxicol       Date:  2013-09       Impact factor: 5.635

Review 5.  Breast cancer animal models and applications.

Authors:  Li Zeng; Wei Li; Ce-Shi Chen
Journal:  Zool Res       Date:  2020-09-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.